Loading organizations...
Loading organizations...
Specialty pharmaceutical company focused on epilepsy and CNS treatments.
Neurelis has raised $264.0M across 2 funding rounds.
Neurelis has raised $264.0M in total across 2 funding rounds.
Neurelis has raised $264.0M in total across 2 funding rounds.
Neurelis's investors include OrbiMed, Cormorant Asset Management, Decheng Capital, HBM Healthcare Investments, LYZZ Capital, Philos & Partners.
Neurelis has raised $264.0M across 2 funding rounds. Most recently, it raised $150.0M Debt in August 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Aug 11, 2021 | $150.0M Debt | OrbiMed | |
| Mar 11, 2021 | $114.0M Series D | Cormorant Asset Management, Decheng Capital, HBM Healthcare Investments, LYZZ Capital, Philos & Partners |